Your browser does not support JavaScript! UREA HYDRATING TOPICAL (UREA) AEROSOL, FOAM [ACELLA PHARMACEUTICALS]
DailyMed Logo Header image

Daily Med

Current Medication Information

Options

RxNorm Names

UREA HYDRATING TOPICAL (urea) aerosol, foam
[Acella Pharmaceuticals]


Category DEA Schedule Marketing Status
HUMAN PRESCRIPTION DRUG LABEL unapproved drug other
NOTE:THIS DRUG HAS NOT BEEN FOUND BY FDA TO BE SAFE AND EFFECTIVE, AND THIS LABELING HAS NOT BEEN APPROVED BY FDA. For further information about unapproved drugs, click here.
Drug Label Sections

DESCRIPTION
Urea 35% Hydrating Topical Foam is a keratolytic emollient in a water and lipid based foam containing lactic acid which is a gentle, but potent, tissue softener for skin and nails.
Each gram of Urea 35% Hydrating Topical Foam contains Urea 35% as the active ingredient, and the following inactive ingredients: dimethicone, ethylparaben, glycerin, lactic acid,
methylparaben, phenoxyethanol, polysorbate 20, povidone, propylene glycol, propylparaben, purified water, stearic acid, trolamine, and in propellants butane and propane.



CHEMICAL STRUCTURE
Urea has the following chemical structure:

ureachemformula

CLINICAL PHARMACOLOGY
Topically applied urea dissolves the intercellular matrix of the skin which results in enhanced shedding of scaly, dry skin and thus a softening of the hyperkeratotic areas of the skin.
Urea topically applied to the nail plate has a similar effect on the intercellular matrix of the nail plate.

PHARMACOKINETICS
The mechanism of action of topically applied urea is not yet known.

INDICATIONS AND USAGE
For enzymatic debridement and promotion of normal healing of surface lesions, particularly where healing is retarded by local infection, necrotic tissue, fibrinous or purulent debris,
or eschar. Topically applied urea is useful for the treatment of hyperkeratotic conditions such as dermatitis, psoriasis, xerosis, ichthyosis, eczema, keratosis, keratoderma, and dry,
rough skin, as well as corns and calluses and damaged, ingrown and devitalized nails.

CONTRAINDICATIONS
Known hypersensitivity to any of the listed ingredients.

WARNINGS
Urea 35% Hydrating Topical Foam is for external use only. It is not for ophthalmic, oral, anal or intravaginal use. Contact with eyes, lips, and all mucous membranes should be
avoided. Urea 35% Hydrating Topical Foam should not be used by persons who have a known hypersensitivity to urea or any of the other listed ingredients.

PRECAUTIONS
Urea 35% Hydrating Topical Foam should be used only as directed by a physician and should not be used to treat any condition other than that for which it is prescribed. If redness
or irritation occurs, discontinue use and consult with a prescribing physician.

Pregnancy (Category B) – Animal reproduction studies have not been performed with topically applied urea and it is not known whether Urea 35% Hydrating Topical Foam can
cause fetal harm when administered to a pregnant woman. Nevertheless, Urea 35% Hydrating Topical Foam should be used by a pregnant woman only if necessary.

Nursing Mothers – It is not known whether topically applied urea is excreted in human milk. Due to the fact that many drugs are excreted in human milk, caution should be
exercised by physicians when administering Urea 35% Hydrating Topical Foam to nursing mothers.

ADVERSE REACTIONS
Transient stinging, burning, itching or irritation is possible.

DOSAGE AND ADMINISTRATION
Unless otherwise directed by a prescribing physician, Urea 35% Hydrating Topical Foam should be applied to affected area twice a day. Urea 35% Hydrating Topical Foam should
be rubbed into the skin until it is completely absorbed.

HOW SUPPLIED
Urea 35% Hydrating Topical Foam is supplied in a 150 gram or 5.3 ounce aerosolized canister bearing the NDC Number 42192-115-15.

Enter section text here

NDC 42192-115-15

Urea 35% Hydrating
Topical Foam

Rx Only
Net Wt. 5.3 oz. (150 g)


NDC 42192-115-15
Rx Only
Net Wt. 5.3 oz. (150 g)
Dosage and Administration: Clean and dry affected
skin. Then apply Urea 35% Hydrating Topical Foam
topically to cover affected skin twice per day, or as
directed by a physician. Rub in until completely absorbed.
Shake vigorously before each application and invert
can to administer.

Store at room temperature 59° - 77°F (15° - 25°C).
See prescribing information for additional details.
Ingredients: urea 35%, dimethicone, ethylparaben,
glycerin, lactic acid, methylparaben, phenoxyethanol,
polysorbate 20, povidone, propylene glycol, propylparaben,
purified water, stearic acid, trolamine, and in
propellants butane and propane.

Warning: Contents under pressure. Do not puncture or
incinerate. Do not expose to temperatures over 120°F
(48°C) even when empty.

Keep out of reach of children.

Manufactured for:
Acella Pharmaceuticals, LLC
Alpharetta, GA 30009
1-800-541-4802


productlabel

UREA HYDRATING TOPICAL 
urea aerosol, foam
Product Information
Product TypeHUMAN PRESCRIPTION DRUG LABELItem Code (Source)NDC:42192-115
Route of AdministrationTOPICALDEA Schedule    
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
UREA (UREA) UREA35 g  in 100 g
Inactive Ingredients
Ingredient NameStrength
DIMETHICONE 
ETHYLPARABEN 
GLYCERIN 
LACTIC ACID 
METHYLPARABEN 
PHENOXYETHANOL 
POLYSORBATE 20 
POVIDONE 
PROPYLENE GLYCOL 
PROPYLPARABEN 
WATER 
STEARIC ACID 
TROLAMINE 
BUTANE 
PROPANE 
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:42192-115-15150 g in 1 CANISTER
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other11/09/2010
Labeler - Acella Pharmaceuticals (825380939)
Registrant - Acella Pharmaceuticals (825380939)
Establishment
NameAddressID/FEIBusiness Operations
Acella Pharmaceuticlas825380939manufacture

Revised: 11/2010
 
Acella Pharmaceuticals

Visit The National Library of Medicine Copyright, Privacy, Accessibility
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services